The abstract is read at the publisher; the summary is JClub's.
Genetic discoveries in Parkinson disease have identified monogenic forms, risk variants, and pathways, enabling increasingly precise diagnosis, prognosis, counseling, and genetically stratified trials.
- Why it matters: PD shows heterogeneous progression and treatment response, and current clinical tools lack biological specificity; genetics aims to fill this gap for precision medicine.
- What they did: This Review traces how three decades of PD genetics uncovered key mechanisms—protein misprocessing, lysosomal and mitochondrial impairment, and altered immune response—and how genetic data are used in clinical decision-making.
- The result: Genetic information is increasingly linked to more personalized care and improved patient outcomes, while also guiding targeted therapeutic innovation and disease-modifying strategies despite challenges like incomplete penetrance and missing heritability across ancestries.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.